Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine

Immunotherapy strategies targeting immune checkpoints such as the CTLA4 and CD274 (programmed cell death 1 ligand 1, PD-L1)/PDCD1 (programmed cell death 1, PD-1) T-cell coreceptor pathways are revolutionising oncology. The approval of pembrolizumab use for solid tumours with high-level microsatellit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gut
Asıl Yazarlar: Ogino, Shuji, Nowak, Jonathan A, Hamada, Tsuyoshi, Phipps, Amanda I, Peters, Ulrike, Milner, Danny A, Giovannucci, Edward L, Nishihara, Reiko, Giannakis, Marios, Garrett, Wendy S, Song, Mingyang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943183/
https://ncbi.nlm.nih.gov/pubmed/29437869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2017-315537
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller